LARANJEIRA CHARLES ANTHONY 4
4 · Pacira BioSciences, Inc. · Filed Aug 5, 2020
Insider Transaction Report
Form 4
LARANJEIRA CHARLES ANTHONY
SVP, Technical Operations
Transactions
- Sale
Common Stock
2020-08-03$52.68/sh−2,500$131,700→ 20,796 total - Exercise/Conversion
Common Stock
2020-08-03−2,500→ 7,500 totalExercise: $44.10Exp: 2027-06-02→ Common Stock (2,500 underlying) - Exercise/Conversion
Common Stock
2020-08-03$44.10/sh+2,500$110,250→ 22,750 total
Footnotes (3)
- [F1]The option exercise and sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
- [F2]Includes 546 shares of common stock acquired under the issuer's employee stock purchase plan in June 2020.
- [F3]The stock option vests and becomes exercisable as to 25% of the option shares on May 1, 2018, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.